CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Telmisartan/ Amlodipine

Last Updated: August 23, 2011
Result type: Reports
Project Number: SR0245-000
Product Line: Reimbursement Review

Generic Name: Telmisartan/ Amlodipine

Brand Name: Twynsta

Manufacturer: Boehringer Ingelheim Canada

Therapeutic Area: Hypertension

Indications: Hypertension, Essential

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 16, 2011

Recommendation Type: List